GT Biopharma, Inc. (GTBP) Return on equity
GT Biopharma, Inc. (GTBP) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-57.3%FY2017
| Fiscal year | Value | YoY |
|---|---|---|
| FY2017 | -57.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More GTBP financial trends
GTBP RevenueGTBP Net incomeGTBP Net marginGTBP Gross profitGTBP Gross marginGTBP Operating incomeGTBP Operating marginGTBP Operating cash flowGTBP Free cash flowGTBP Capital expendituresGTBP Stock buybacksGTBP Dividends paidGTBP Total assetsGTBP Total liabilitiesGTBP Shareholders’ equityGTBP overview →